PULMATRIX, INC. Increase (Decrease) in Restricted Cash for Operating Activities
PULMATRIX, INC. (PULM) reported Increase (Decrease) in Restricted Cash for Operating Activities of -$46.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2017-11-09
- PULMATRIX, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2016-12-31 was $0.00.
- PULMATRIX, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2016-09-30 was $0.00.
- PULMATRIX, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2016-06-30 was $4.00K, a 300.00% increase year-over-year.
- PULMATRIX, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2016-03-31 was -$50.00K, a 2600.00% decline year-over-year.
- PULMATRIX, INC. increase (decrease) in restricted cash for operating activities for fiscal 2016 was -$46.00K.
- PULMATRIX, INC. increase (decrease) in restricted cash for operating activities for fiscal 2014 was $25.00K.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 6 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $4.00K derived: sum of 3 quarters · filed 2017-11-09 | -$46.00K 10-K · filed 2017-03-10 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $4.00K derived: sum of 2 quarters · filed 2017-11-09 | -$46.00K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$46.00K 10-Q · filed 2017-08-04 | ||
| 2016-03-31 | -$50.00K 10-Q · filed 2017-05-05 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $1.00K derived: sum of 2 quarters · filed 2016-11-04 | $3.00K 10-Q · filed 2016-11-04 | $1.00K derived: sum of 4 quarters · filed 2016-11-04 |
| 2015-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $3.00K 10-Q · filed 2016-08-04 | $1.00K derived: sum of 3 quarters · filed 2016-08-04 | $1.00K derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | $2.00K 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2016-05-05 | $0.00 derived: sum of 3 quarters · filed 2016-05-05 | |
| 2014-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$2.00K derived: sum of 2 quarters · filed 2016-03-10 | $25.00K 10-K · filed 2016-03-10 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $27.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $27.00K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |